NCT02389790View on ClinicalTrials.gov

Extension Study of MT-1303 in Subjects With Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Crohn's Disease
Interventions
DRUG

MT-1303

Trial Locations (11)

Unknown

Investigational site, City Name

Investigational site, City Name

Investigational site, City Nmae

Investigational site, City Nmae

Investigational site, City Name

Investigational site, City Name

Investigational site, City Nmae

Investigational site, City Name

Investigational site, City Name

Investigational site, City Name

Investigational site, City Name

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY